ORIGINAL ARTICLE : Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn`s Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study

논문상세정보
' ORIGINAL ARTICLE : Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn`s Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • adalimumab
  • crohn disease
  • efficacy
  • safety
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
945 0

0.0%